Kawanishi, Japan

Ryo Nakayama

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryo Nakayama. Retrieved from https://idiyas.com/inventor/ryo-nakayama-iiop5hsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryo Nakayama: Innovator in Steroid Compounds

Introduction

Ryo Nakayama is a notable inventor based in Kawanishi, Japan. He has made significant contributions to the field of steroid compounds, particularly with his innovative patent that showcases novel steroid structures. His work is recognized for its potential applications in medical treatments.

Latest Patents

Ryo Nakayama holds a patent for "17-Nor-6-methyl-steroids," which presents novel steroid compounds represented by a specific chemical formula. These compounds exhibit strong anti-androgenic activity, especially when administered orally. They are particularly promising as remedies for prostatomegaly, highlighting their potential therapeutic benefits.

Career Highlights

Nakayama is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work there has allowed him to focus on the development of innovative steroid compounds that could have significant impacts on health and medicine.

Collaborations

Throughout his career, Ryo Nakayama has collaborated with esteemed colleagues such as Giichi Goto and Michio Masuoka. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Ryo Nakayama's contributions to the field of steroid compounds through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to improve treatment options for various health conditions, particularly prostatomegaly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…